publication venue for
- Cardiovascular toxicities of BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: preventive strategies and cardiovascular surveillance. Volume 13:293-303. 2017
- The effects of timing of prophylaxis, type of anesthesia, and use of mechanical methods on outcome in major orthopedic surgery - subgroup analyses from 17,701 patients in the XAMOS study. 12:209-209. 2016
- Profile of betrixaban and its potential in the prevention and treatment of venous thromboembolism. 11:343-343. 2015
- Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty. 10:157-157. 2014
- Practical guidance for using rivaroxaban in patients with atrial fibrillation: balancing benefit and risk. 10:101-101. 2014
- XANTUS: rationale and design of a noninterventional study of rivaroxaban for the prevention of stroke in patients with atrial fibrillation. 10:425-425. 2014
- Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgery. 8:363-363. 2012
- Effectiveness of percutaneous laser revascularization therapy for refractory angina. 6:735-735. 2010
- Effects of study design and trends for EVAR versus OSR. Volume 4:1011-1022. 2008
- Management of venous thromboembolism in patients with cancer: role of dalteparin. Volume 4:279-287. 2008
- Arterial stiffness and pharmacological interventions--the TRanscend arterial stiffNess Substudy (TRANS study).. 3:381-387. 2007
- Clinical update on the therapeutic use of clopidogrel: treatment of acute ST-segment elevation myocardial infarction (STEMI). 2:379-387. 2006
- Fondaparinux in the management of patients with ST-elevation acute myocardial infarction. 2:371-378. 2006